Navigation Links
Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon

- Albuferon 900-mcg dosed every two weeks achieved an SVR rate at least comparable to Pegasys dosed every week (ITT analysis), with more favorable quality-of-life scores -

ROCKVILLE, Md., June 07, 2007 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. today announced the top-line final results of a Phase 2b clinical trial of Albuferon(R) (albinterferon alfa-2b) in combination with ribavirin in treatment-naive patients with genotype 1 chronic hepatitis C. The Company expects to make a full presentation of the final results at an appropriate scientific meeting later in 2007.

"The final Phase 2b results confirm and extend the findings of several studies, which suggest that Albuferon may offer efficacy at least comparable to peginterferon alfa-2a, with half the injections and possibly less impairment of quality of life," said John McHutchison, M.D., Coordinating Center Principal Investigator for the Phase 2b trial, and Professor of Medicine and Associate Director, Duke Clinical Research Institute and Duke University Medical Center, Durham, North Carolina. "We are extremely pleased with the high quality of the data that have emerged from the Phase 2b study, and we look forward to continuing the evaluation of the 900-mcg and 1200-mcg doses of Albuferon in larger populations in Phase 3 trials."

The primary efficacy endpoint of the Phase 2b trial of Albuferon was sustained virologic response (SVR), defined as undetectable viral load (HCV RNA<10 IU/mL) at 24 weeks following completion of therapy. The final results demonstrated that Albuferon provided at least comparable efficacy vs. Pegasys (peginterferon alfa-2a), based on an ITT analysis. The treatment group receiving Albuferon 900-mcg doses every two weeks achieved an SVR rate of 58.5%, vs. 57.9% for the group receiving Pegasys once every week (ITT analysis). This Albuferon treatment group also had more favorable health- related quality-of-life scor
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Testing for Human Papillomavirus
2. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
3. Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog Liraglutide, Brings Patients to A1c Target
4. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
5. Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin
6. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
7. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
8. Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
9. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
10. Research Indicates Gerons Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack by the Human Immune System
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
Post Your Comments:
(Date:5/24/2013)... -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL ) today ... Bank Health Care Conference to be held May 29-30 ... Adrian Adams , Chief Executive Officer and President, ... and its product pipeline at 12:00 p.m. ET on ... http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) The presentation will also be ...
(Date:5/24/2013)... and BOSTON , May 24, 2013 ... and development company, is pleased to announce that it has engaged ... augment the Company,s business development capabilities in Japan ... than 15 years of experience in business development, licensing and alliance ... Inc., Roche Pharma ( Japan ), Nippon Roche and ...
(Date:5/23/2013)... 23, 2013 Neurocrine Biosciences, Inc. (Nasdaq: ... , President and Chief Executive Officer of Neurocrine Biosciences, will ... dbAccess Health Care Conference in Boston.   The ... a.m. Eastern Time / 8:20 a.m. Pacific Time.  The presentation ... website at http://www.neurocrine.com . If you ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2
... Jan. 25, 2012 Boston IVF, a leading medical ... it has introduced the first needle-free saliva test that ... treatment. Following nearly two years of research, Boston IVF ... the blood, can also be accurately measured in saliva, ...
... FORT COLLINS, Colo., Jan. 25, 2012  Integware today ... Systems Integrator Partnership Agreement with Siemens PLM Software, ... (PLM) software and services. Integware has focused for ... product-related processes in the medical device industry. Its ...
Cached Medicine Technology:Boston IVF Pioneers World's First Needle-Free Saliva Test Used in Infertility Treatment; Patient Friendly Monitoring Replaces Daily Blood Tests 2Boston IVF Pioneers World's First Needle-Free Saliva Test Used in Infertility Treatment; Patient Friendly Monitoring Replaces Daily Blood Tests 3Integware Announces Systems Integrator Agreement With Siemens PLM Software 2
(Date:5/24/2013)... -- Nearly three out of four pregnant women ... but these issues don,t significantly affect their quality ... from Loyola University Medical Center in Maywood, Ill., ... physiological and hormonal changes that occur during pregnancy. ... can play a role. The study authors added ...
(Date:5/24/2013)... to the new market research report “Micro Irrigation System ... by MarketsandMarkets, global micro irrigation system market expected to ... 2010 and is expected to reach $3,414.7 million by ... to 2016. , Browse:, , 150 ... 370 pages and in-depth Table Of Content ...
(Date:5/24/2013)... Toronto, ON (PRWEB) May 24, 2013 ... for hosted voice, video, data, and IT security ... ability to reduce communication costs by more than ... Via a Limited Time Hosted PBX Bundle Pricing. ... the nation in touch with VoIP. , Starting ...
(Date:5/24/2013)... CA (PRWEB) May 24, 2013 Chronic ... illness that plagues sufferers with unexplained fatigue lasting 6 ... include short term memory and concentration impairment, muscle and ... tender lymph nodes, un-refreshing sleep and malaise that lasts ... obesity are now known to be linked to insulin ...
(Date:5/24/2013)... NS (PRWEB) May 24, 2013 Today ... the all-new online Itinerary Builder. , The redesigned ... easily create unique vacation itineraries on their computer or ... , The interactive tool allows users to fill ... then browse through and select their choice of vacation ...
Breaking Medicine News(10 mins):Health News:Bowel Issues Affect 3 Out of 4 Pregnant Women 2Health News:Micro Irrigation System Market to Reach $3414.7 Million by 2016 at a CAGR of 17.9% - New Report by MarketsandMarkets 2Health News:Micro Irrigation System Market to Reach $3414.7 Million by 2016 at a CAGR of 17.9% - New Report by MarketsandMarkets 3Health News:BroadConnect Is Offering New Hosted PBX Bundle Pricing for New Customers, Eliminating VoIP Adoption Barriers 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces New hCG Diet Plans to Promote Fast Weight Loss Shown to Reduce the Risk & Symptoms of Chronic Fatigue 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces New hCG Diet Plans to Promote Fast Weight Loss Shown to Reduce the Risk & Symptoms of Chronic Fatigue 3Health News:Create and Win the Perfect Halifax Getaway with the All-New Itinerary Builder 2
... for,Nursing is collaborating with a number of national ... Advanced Practice Registered Nurses,(APRNs) have on healthcare quality ... kind in 20 years, researchers will examine the,evidence ... four APRN roles --,Clinical Nurse Specialists, Nurse Anesthetists, ...
... a nationwide study to explore an investigational treatment for ... Emphysema) Trial focuses on airway bypass, a minimally invasive ... of breath typical complications of emphysema - by ... lungs. , During the airway bypass procedure, ...
... As Senators Barack,Obama and John McCain arrive in Oxford, ... by AIDS activists from across the,country demanding that the ... 100 days in office., On Friday, September 26, ... -,AIDS activists will hold a demonstration and mock funeral ...
... is reminding,all Los Angeles residents that they have just one ... enforcement begins on October 1,2008., On February 12, 2008, ... requires all cats and dogs in the City to be ... specific exemptions allowed. Mayor,Villaraigosa signed this ordinance into law on ...
... The U.S. Pharmacopeial (USP) Convention is pleased ... Reference Material (CRM), Dextromethorphan Hydrobromide. USP recently became ... for Standardization accreditation as producer of chemical CRMs. ... a new class of reference standard that ensures ...
... of liver cirrhosis is still high, although new ... no established therapy for liver fibrosis, and Authors ... Soup on liver fibrosis induced by DMN in ... fibrosis resulted from chronic liver injure, retard the ...
Cached Medicine News:Health News:27 National Nursing Organizations Join Together to Commission a Study of the Impact of Advanced Practice Registered Nurses on Healthcare Quality, Safety, and Effectiveness 2Health News:27 National Nursing Organizations Join Together to Commission a Study of the Impact of Advanced Practice Registered Nurses on Healthcare Quality, Safety, and Effectiveness 3Health News:Potential treatment option for severe emphysema under study 2Health News:AIDS Activists from Across the Country Converge on Oxford, Mississippi, to Call on McCain and Obama to Commit to National AIDS Strategy 2Health News:New Los Angeles Spay and Neuter Law Goes Into Effect on October 1 2Health News:An effective strategy for inhibition of cirrhosis 2
The Mini Vidas is a compact version of the Vidas system with a built-in computer, keyboard and printer. Two independent sections each accept six tests and can process up to 12 samples simultaneously....
The Mini Vidas is a compact version of the Vidas system with a built-in computer, keyboard and printer. Two independent sections each accept six tests and can process up to 12 samples simultaneously....
The ACE Alera clinical chemistry system serves a wide variety of chemistry diagnostic needs with the power of a large floor model analyzer in an easily integrated and economizing compact footprint of...
... For physicians looking for a ... advanced communications with electronic storage ... the best of both worlds. ... easy-to-use features of the Atria ...
Medicine Products: